Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
+8.19%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$2.51B
Cap. Flow %
-3.43%
Top 10 Hldgs %
11.25%
Holding
4,601
New
625
Increased
1,395
Reduced
2,029
Closed
525

Top Buys

1
AAPL icon
Apple
AAPL
+$763M
2
AMZN icon
Amazon
AMZN
+$688M
3
TSM icon
TSMC
TSM
+$562M
4
TSLA icon
Tesla
TSLA
+$419M
5
JNJ icon
Johnson & Johnson
JNJ
+$398M

Sector Composition

1 Healthcare 20.8%
2 Technology 15.52%
3 Consumer Discretionary 11.85%
4 Consumer Staples 10.11%
5 Financials 9.6%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CVM icon
3776
CEL-SCI Corp
CVM
$67.7M
$56K ﹤0.01%
801
+362
+82% +$25.3K
ERNA icon
3777
Eterna Therapeutics
ERNA
$10.6M
$56K ﹤0.01%
1,169
-3,696
-76% -$177K
IOBT icon
3778
IO Biotech
IOBT
$126M
$56K ﹤0.01%
24,200
+5,777
+31% +$13.4K
DWTX
3779
Dogwood Therapeutics, Inc. Common Stock
DWTX
$9.36M
$56K ﹤0.01%
9,416
+2,352
+33% +$14K
NURO
3780
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$55K ﹤0.01%
4,607
+1,082
+31% +$12.9K
ADIL
3781
Adial Pharmaceuticals
ADIL
$7.7M
$54K ﹤0.01%
10,075
+4,306
+75% +$23.1K
MBOT icon
3782
Microbot Medical
MBOT
$189M
$54K ﹤0.01%
17,995
-1,100
-6% -$3.3K
NBSE
3783
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$54K ﹤0.01%
14,261
-108
-0.8% -$409
AKAN icon
3784
Akanda
AKAN
$2.47M
$53K ﹤0.01%
142
+131
+1,191% +$48.9K
AMBO
3785
Ambow Education Holding
AMBO
$10.3M
$53K ﹤0.01%
17,314
-620
-3% -$1.9K
DMAC icon
3786
DiaMedica Therapeutics
DMAC
$376M
$53K ﹤0.01%
+33,619
New +$53K
ASXC
3787
DELISTED
Asensus Surgical, Inc.
ASXC
$53K ﹤0.01%
152,473
+56,300
+59% +$19.6K
RHE
3788
DELISTED
Regional Health Properties, Inc.
RHE
$53K ﹤0.01%
16,100
-245
-1% -$807
FURY
3789
Fury Gold Mines
FURY
$113M
$52K ﹤0.01%
122,724
+61,500
+100% +$26.1K
OST icon
3790
Ostin Technology Group
OST
$9.11M
$52K ﹤0.01%
220
+68
+45% +$16.1K
PRSO icon
3791
Peraso
PRSO
$7.66M
$52K ﹤0.01%
1,785
-295
-14% -$8.59K
PRDS
3792
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$51K ﹤0.01%
+29,886
New +$51K
HUMA icon
3793
Humacyte
HUMA
$238M
$50K ﹤0.01%
23,800
-184,200
-89% -$387K
JFIN
3794
Jiayin Group
JFIN
$578M
$50K ﹤0.01%
21,896
+7,196
+49% +$16.4K
YGMZ icon
3795
MingZhu Logistics Holdings
YGMZ
$58.4M
$50K ﹤0.01%
7,369
+1,794
+32% +$12.2K
VORB
3796
DELISTED
Virgin Orbit Holdings, Inc. Common Stock
VORB
$50K ﹤0.01%
+26,800
New +$50K
THER
3797
DELISTED
THERATECHNOLOGIES INC COM
THER
$50K ﹤0.01%
+56,400
New +$50K
HSDT icon
3798
Helius Medical Technologies
HSDT
$7.9M
$49K ﹤0.01%
4
-4
-50% -$49K
RDHL
3799
Redhill Biopharma
RDHL
$3.67M
$49K ﹤0.01%
+349
New +$49K
TC
3800
TuanChe
TC
$31.2M
$49K ﹤0.01%
197
+31
+19% +$7.71K